Sabrina is a 26 year old female who has just been diagnosed with multiple sclerosis.
For the assignment we will use the decision tree on COMPLEX REGIONAL PAIN DISORDER. The decision tree is available under Resources, Required Media for Week 6. I included a screen shot below for your convenience. Please DO NOT use the decision tree on Alzheimer’s disease. You will receive a zero.
Write a 1- to 2-page summary paper that addresses the following:
- Briefly summarize the patient case study you were assigned, including each of the three decisions you took for the patient presented.
- In this scenario, pretend you are seeing this patient for a visit at your office. Decide which one of the three decisions would be most appropriate (decision point 1). Once you click on your decision, the tree will provide information on what happened since the last visit (4 weeks ago) and you need to decide which of the next three options will be the best (decision point 2). Once you click on your decision, the tree will guide you to the final visit (4 weeks later), provide information on what happened the last 4 weeks and present you with the next three decisions (decision point 3).
- Include a brief description of the most important information from the patient case.
- Then describe your decisions at decision points #1, #2 and #3. Note, points are not awarded based on what your decision at each step was (there is no wrong answer, though there is a more appropriate choice at each decision point).
- Based on the decisions you recommended for the patient case study, explain whether you believe the decisions provided were supported by the evidence-based literature (EBL). Be specific and provide examples. Be sure to support your response with evidence and references from outside resources.
- EBL refers to primary research studies done on this disease state and the treatments at each decision point. Primary research includes randomized controlled trials and systematic reviews.
- You need to provide a short summary of the research study and cite the study. Make sure the study fits your patient.
- Do NOT cite a textbook or any Walden material. You can use the Reference Lists from the textbook, Walden material and treatment guidelines to identify primary research studies, but you must cite the primary research studies.
- What were you hoping to achieve with the decisions you recommended for the patient case study you were assigned? Support your response with evidence and references from outside resources.
- All of us wants our patients to improve. EBL indicates a.) time to therapeutic effect, b.) the size of the therapeutic effect, c.) side effects one can expect from a drug treatment and d.) if one treatment is more effective than others.
- For this section, you need to include the results from the study you based your decision on for decision points #1, #2 and #3. You must cite the primary research studies.
- Explain any difference between what you expected to achieve with each of the decisions and the results of the decision in the exercise. Describe whether they were different. Be specific and provide examples.
- Here you need to compare the results from the EBL to what happened in practice (the feedback provided by the decision tree).
- Refer to a.) time to therapeutic effect, b.) the size of the therapeutic effect, c.) side effects one can expect from a drug treatment and d.) if one treatment is more effective than others.
HERE IS THE CASE STUDY:
Sabrina is a 26 year old female who has just been diagnosed with multiple sclerosis. She has scheduled an appointment for a follow up with her physician but has several questions about her diagnosis and is calling the Nurse Helpline for her hospital network. As she talks with the advanced practice nurse, she learns that her diagnosis also impacts her neurologic and musculoskeletal systems. Although multiple sclerosis is an autoimmune disorder, both the neurologic and musculoskeletal systems will be affected by adverse symptoms that Sabrina needs to be aware of and for which specific drug therapy plans and other treatment options need to be decided on.
As an advanced practice nurse, what types of drugs will best address potential neurologic and musculoskeletal symptoms Sabrina might experience?
DECISION TREE LINK FOR COMPLEX REGIONAL PAIN RELIEF:
Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
- Chapter 11, “Basic Principles of Neuropharmacology” (pp. 67–71)
- Chapter 12, “Physiology of the Peripheral Nervous System” (pp. 72–81)
- Chapter 12, “Muscarinic Agonists and Cholinesterase Inhibitors” (pp. 82–89)
- Chapter 14, “Muscarinic Antagonists” (pp. 90-98)
- Chapter 15, “Adrenergic Agonists” (pp. 99–107)
- Chapter 16, “Adrenergic Antagonists” (pp. 108–119)
- Chapter 17, “Indirect-Acting Antiadrenergic Agents” (pp. 120–124)
- Chapter 18, “Introduction to Central Nervous System Pharmacology” (pp. 125–126)
- Chapter 19, “Drugs for Parkinson Disease” (pp. 127–142)
- Chapter 20, “Drugs for Alzheimer Disease” (pp. 159–166)
- Chapter 21, “Drugs for Seizure Disorders” (pp. 150–170)
- Chapter 22, “Drugs for Muscle Spasm and Spasticity” (pp. 171–178)
- Chapter 59, “Drug Therapy of Rheumatoid Arthritis” (pp. 513–527)
- Chapter 60, “Drug Therapy of Gout” (pp. 528–536)
- Chapter 61, “Drugs Affecting Calcium Levels and Bone Mineralization” (pp. 537–556)